Isomorphic Labs: AI Drug Design Engine Approaches Clinical Trials
Isomorphic Labs raised $2.1B to scale its IsoDDE AI drug design engine toward first-in-human clinical trials by end of 2026.
Posts by Nexi.fund Labs
A Guide to Military Unmanned Ground Vehicles: Platforms Reshaping Land Defence
Military UGVs are transitioning from prototype experiments to production programs. This Radar examines the platforms, programs, and procurement trends reshaping land warfare.
AI Infrastructure Capex Hits $941.5 Billion — The Largest Capital Buildout in Tech History
The combined capital expenditure tracked across 45 companies reached $941.5 billion as of July 2026, with $399.5 billion directly attributable to AI. The Big Four account for $580 billion of the total.
Nuclear-Powered AI Data Centers: Hyperscalers Reshape the Energy Grid
Hyperscalers have committed 9.8 GW of nuclear capacity for AI data centers, signing 13 deals worth billions. Nuclear is no longer optional for AI infrastructure.
Beeline Medicines Raises 126.3 Million Series A for Autoimmune Therapies
Bain Capital, CPP Investments and BMS backed Beeline Medicines with a 126.3 million Series A extension, bringing total funding to 426.3 million for a precision immunology pipeline led by lupus drug afimetoran.
Digit at Work: Agility Robotics' Humanoid Passes the Commercial Test
Agility Robotics' Digit is the first bipedal humanoid generating revenue from paying customers. 75 units deployed, 4 commercial agreements, and a RaaS model that changes the economics of humanoid robotics.
GPU Cloud vs Hyperscaler: The 2026 AI Infrastructure Cost Comparison
Neocloud GPU pricing runs 40–85% below hyperscalers, but egress, idle cycles, and workload type can erase the savings. Here is how to calculate total cost per token and per training step.
The $650M Bet on Space Defense: True Anomaly and the Golden Dome Program
True Anomaly raised $650M at $2.2B valuation for the Space Force Golden Dome program — the largest single raise by a space defense startup.